WASHINGTON (AP) — President Donald Trump on Monday signed into law the Take It Down Act, a measure that imposes penalties for ...

In recent years, India’s STEM landscape has been quietly but profoundly reshaped by women who are breaking norms, challenging defaults, and redefining what leadership in science and technology looks ...

Moody’s had been a holdout in keeping U.S. sovereign debt at the highest credit rating possible, and brings the 116-year-old ...

When it comes to infertility treatment and especially IVF (In Vitro Fertilization) only a few select Doctors command as much respect and recognition as Dr. Mona Dahiya.

It is now illegal to publish or threaten to publish real or AI-generated intimate images of a person without their consent. Tech sites and companies also must take down such images within 48 hours of ...

The development of Phenesafe AI is driven by PharmAla’s drug development philosophy: Development of deep expertise in one specific drug class PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB ...

The development of Phenesafe AI will help us do all of these elements more quickly, and effectively.” PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF) is a biotechnology company focused on the ...

You can reach Jason on Signal at JasonMast.05. Insitro, the closely watched AI biotech founded by the Stanford professor and entrepreneur Daphne Koller, said Thursday it was laying off 22% of its ...

TORONTO, May 15, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla ... to formally announce the launch of the Phenesafe AI platform, an AI technology stack specifically ...

PharmAla Biotech.“All the while, you must continue to keep focus on your goals: indication, safety profile, and intended function. The development of Phenesafe AI will help us do all of these ...

On May 13, 2025, Viva Biotech successfully held the AIDD platform launch event "Enchantment of Drug Discovery," unveiling the advanced and comprehensive AI-Driven Drug Discovery (AIDD) platform to ...

Viva Biotech adopts an AI-driven antibody discovery workflow that takes a completely different route by starting with AI-generated sequences, rather than relying on traditional methods like animal ...